Drug Shortage Report for AURO-ROSUVASTATIN
Report ID | 217664 |
Drug Identification Number | 02442574 |
Brand name | AURO-ROSUVASTATIN |
Common or Proper name | AURO-ROSUVASTATIN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90's |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-01-29 |
Estimated end date | 2024-09-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-08-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2024-08-13 | French | Compare |
v16 | 2024-08-13 | English | Compare |
v15 | 2024-07-29 | French | Compare |
v14 | 2024-07-29 | English | Compare |
v13 | 2024-07-02 | French | Compare |
v12 | 2024-07-02 | English | Compare |
v11 | 2024-05-30 | French | Compare |
v10 | 2024-05-30 | English | Compare |
v9 | 2024-04-29 | French | Compare |
v8 | 2024-04-29 | English | Compare |
v7 | 2024-03-27 | French | Compare |
v6 | 2024-03-27 | English | Compare |
v5 | 2024-02-27 | French | Compare |
v4 | 2024-02-27 | English | Compare |
v3 | 2024-01-30 | English | Compare |
v2 | 2024-01-29 | French | Compare |
v1 | 2024-01-29 | English | Compare |
Showing 1 to 17 of 17